Filing Details
- Accession Number:
- 0000899866-15-000082
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-20 17:02:51
- Reporting Period:
- 2015-03-19
- Filing Date:
- 2015-03-20
- Accepted Time:
- 2015-03-20 17:02:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899866 | Alexion Pharmaceuticals Inc | ALXN | Pharmaceutical Preparations (2834) | 133648318 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1231949 | Leonard Bell | C/O Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire CT 06410 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $.0001 Per Share | Disposition | 2015-03-19 | 15,952 | $188.07 | 949,426 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
- The sale of common stock reported by this Form 4 consists of shares of Alexion common stock contributed by the reporting person to an exchange fund in exchange for shares of the exchange fund. The Alexion shares were valued at $188.07 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person.